FundedIQ
Biotechnology

BoobyBiome: Funding, Investors & Team (Oct 2026)

BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes. We aim to promote healthy infant development by recreating the beneficial bacteria associated with breast milk.

www.boobybiome.com LinkedIn London, United Kingdom 1-10 employees
Biotechnology Health Care Life Science Formula milk Medical research Supplement powder And infant nutrition
Total raised
$3.6M
Rounds
2
Latest
Seed
Sep 2025

BoobyBiome has raised $3.6M across 2 funding rounds on record, the most recent a Seed of $3.4M announced in Sep 2025.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

BoobyBiome Company Profile and Key Stats

Total funding raised
$3.6M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Seed
$3.4M in Sep 2025
Employees
1-10
reported band
Headquarters
London, United Kingdom

Latest funding round on record: Sep 2025.

BoobyBiome Funding Rounds

Date
Round
Amount
Seed
$3.4M
Undisclosed round
$180k

BoobyBiome raised $180k in an undisclosed round announced in Apr 2023.

2.4 years later, a Seed of $3.4M was announced in Sep 2025.

BoobyBiome Founders and Leadership Team

Name
Role
Contact
Lydia Mapstone
CEO
Locked

Contact details for the BoobyBiome team: 1 of 1 has an email address on file.

Start 14-day free trial →

BoobyBiome Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
5,368
$4.1M
17,153
$3.1M

BoobyBiome's latest round of $3.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like BoobyBiome in Biotechnology and London

Companies Similar to BoobyBiome

Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…

Series C $40.4M

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…

Series C $310M

HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…

Series A $8.0M

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

BoobyBiome Funding FAQs

What does BoobyBiome do?

BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes. We aim to promote healthy infant development by recreating the beneficial bacteria associated with breast milk.

How much funding has BoobyBiome raised?

BoobyBiome has raised $3.6M across 2 rounds on record. The most recent is a Seed of $3.4M announced in Sep 2025.

When did BoobyBiome last raise funding?

BoobyBiome's most recent funding round on record is a Seed of $3.4M, announced in Sep 2025.

Who is the CEO of BoobyBiome?

Lydia Mapstone is listed as CEO at BoobyBiome.

Where is BoobyBiome headquartered?

BoobyBiome is based in London, England, United Kingdom.

How many employees does BoobyBiome have?

BoobyBiome is in the 1-10 employee band.

How does BoobyBiome's funding compare to other Biotechnology startups?

BoobyBiome's latest round of $3.4M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's BoobyBiome Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BoobyBiome is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.